Sort
11,323 grants matching “glioblastoma”
SU 101 VERSUS PROCARBAZINE FOR PATIENTS W/ GLIOBLASTOMA
$0University Of Southern California · M01 · FY2002 · RR
Glial cell differentiation /low grade glioma formation
$0Sloan-Kettering Institute For Cancer Res · P20 · FY2002 · CA
UPCC7399: PYRAZOLACRIDINE IN ADULTS W NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
$0University Of Pennsylvania · M01 · FY2000 · RR
Imaging tumor progression &metastasis caused by deletion of PTEN
$0University Of California Los Angeles · P50 · FY2000 · CA
SU101 FOR PATIENTS WITH ANAPLASTIC ASTROCYTOMA RELAPSE
$0University Of Southern California · M01 · FY2000 · RR
RSR13 IN GLIOBLASTOMA MULTIFORME RADIATION THERAPY PTS
$0Pennsylvania State Univ Hershey Med Ctr · M01 · FY2000 · RR
Thrombin Cleavage of Osteopontin Suppresses Host-Anti-Tumor Immune Response in Cancer
$0Lawrence L Leung · Veterans Admin Palo Alto Health Care Sys · I01 · FY2023 · VA
PHASE II STUDY TO EVALUATE RSR13 THERAPY WITH RADIATION FOR GLIOBLASTOMA
$0Northwestern University · M01 · FY2000 · RR
HuR and RNA regulation as a Novel Therapeutic Target in Malignant Glioma
$0Peter H King · Birmingham Va Medical Center · I01 · FY2015 · VA
Molecular Pathogenesis
$0Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2006 · NS
Drug Delivery Techniques
$0Neurological Disorders And Stroke · Z01 · FY2005 · NS
Neuro-oncology
$0Edward H Oldfield · Neurological Disorders And Stroke · Z01 · FY2006 · NS
Monoclonal antibody inhibition of thrombin cleavage of osteopontin as a novel therapeutic to enhance host antitumor immunity and reduce cardiac fibrosis
$0Lawrence L Leung · Veterans Admin Palo Alto Health Care Sys · I01 · FY2025 · VA
NEURO-ONCOLOGY
$0Neurological Disorders And Stroke · Z01 · FY2000 · NS
Artificial Intelligence-based decision support for chemotherapy-response assessment in Brain Tumors
$0Pallavi Tiwari · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2025 · VA
GENE THERAPY USING HSV TK GENE WITH ADMINISTRATION OF GANCICLOVIR IN ADULTS
$0Baylor College Of Medicine · M01 · FY2001 · RR
Mechanisms of Resistance to mTOR-Targeted Therapies
$0Joseph F Gera · Va Greater Los Angeles Healthcare System · I01 · FY2016 · VA
Immune Dysregulation in Cancer
$0Basic Sciences · Z01 · FY2001 · BC
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME IN FIRST RELAPSE
$0Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2000 · RR
Development of Recombinant Toxins for Treatment of Patie
$0Basic Sciences · Z01 · FY2001 · BC
A Phase I Study of Hydroxyurea and Pentoxifylline For Tr
$0Clinical Sciences · Z01 · FY2001 · SC
GENE THERAPY FOR RECURRENT GLIOBLASTOMA MULTIFORME--PHASE I TRIAL
$0Mount Sinai School Of Medicine Of Cuny · M01 · FY2002 · RR
Immunotoxin Therapy in Cancer
$0Basic Sciences · Z01 · FY2001 · BC
Immune Dysregulation in Cancer
$0Basic Sciences · Z01 · FY2000 · BC
RSR13 ADMINISTERED TO PATIENTS RECEIVING CRANIAL RADIATION THERAPY
$0University Of Pennsylvania · M01 · FY2000 · RR